Fifth Third Bancorp
TRIB

Fifth Third Bancorp’s Trinity Biotech TRIB Stock Holding History

Fifth Third Bancorp’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-300
Closed -$17K – 2883
2015
Q3 		$17K Sell
300
-200
-40% -$16.1K ﹤0.01% 1804
2015
Q2 		$45K Buy
+500
New +$43.3K ﹤0.01% 1490

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Fifth Third Bancorp's TRIB Position: Q4 2015 in Review

Fifth Third Bancorp sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 300 shares — an estimated $17K sold.

Fifth Third Bancorp first reported a position in TRIB in Q2 2015 and held it in 2 quarters. The position peaked at $45K in Q2 2015. 82 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

  • Fifth Third Bancorp reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 300 Trinity Biotech shares in Q4 2015, an estimated $17K.
  • Fifth Third Bancorp first reported a position in Trinity Biotech in Q2 2015 and held it in 2 quarters.
  • Fifth Third Bancorp's Trinity Biotech position peaked at $45K in Q2 2015.
  • 82 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on Fifth Third Bancorp's 13F filing for Q4 2015, filed 16 Feb 2016.